文献速递胸部CT

深度学习特征预测肺腺癌淋巴结转移:与影像组学及临床-语义模型的比较

Development and validation of a deep learning signature for predicting lymph node metastasis in lung adenocarcinoma: comparison with radiomics signature and clinical-semantic model.
PubMed 文献 · Eur Radiol · 2022-09-28

该回顾性研究纳入612例病理确诊肺腺癌患者(训练489例、内部验证123例)及108例独立测试队列,基于增强CT构建Swin Transformer深度学习特征预测淋巴结转移。深度学习特征在三个队列中AUC达0.948-0.961,显著优于临床-语义模型和影像组学特征(均p<0.05),校准曲线良好且净获益更高。

要点

  • 深度学习特征预测肺腺癌淋巴结转移AUC 0.948-0.961,优于影像组学与临床-语义模型。
  • 深度学习特征校准良好,决策曲线净获益高于两种对照模型。
  • 将影像组学或临床-语义风险预测因子加入深度学习特征未见增量价值。

核心结论

  • 基于Swin Transformer的深度学习特征在预测肺腺癌淋巴结转移方面表现优异,可为无创纵隔淋巴结分期和个体化治疗选择提供重要信息。

研究设计与样本

  • 回顾性研究,共纳入612例病理确诊肺腺癌患者,随机分为训练队列489例和内部验证队列123例,另设独立测试队列108例。
  • 收集患者临床特征和CT语义特征,影像组学特征源自增强CT图像。
  • 构建临床-语义模型和影像组学特征预测淋巴结转移,并采用Swin Transformer开发深度学习特征。
  • 模型性能通过AUC、敏感度、特异度、校准曲线和决策曲线分析评估,AUC比较采用DeLong检验。

诊断标准与关键数值

  • 深度学习特征在全部三个队列中预测淋巴结转移的AUC为0.948-0.961,显著优于临床-语义模型和影像组学特征(均p<0.05)。
  • 校准曲线显示深度学习特征预测概率与实际观察概率拟合良好。
  • 深度学习特征净获益高于临床-语义模型和影像组学特征。
  • 将影像组学特征或临床-语义风险预测因子纳入深度学习特征未显示增量价值。

临床应用与阅片要点

  • 深度学习特征可作为无创预测肺腺癌淋巴结转移的辅助工具,辅助纵隔淋巴结分期。
  • 深度学习特征表现优于传统影像组学和临床-语义模型,阅片时可关注其预测结果。
  • 加入影像组学或临床-语义风险预测因子未提升深度学习特征性能,提示无需常规联合。

局限性

  • 研究为回顾性设计。
  • 外部验证仅一个独立测试队列(n=108),多中心泛化能力需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To develop and validate a deep learning (DL) signature for predicting lymph node (LN) metastasis in patients with lung adenocarcinoma.

METHODS: A total of 612 patients with pathologically-confirmed lung adenocarcinoma were retrospectively enrolled and were randomly divided into training cohort (n = 489) and internal validation cohort (n = 123). Besides, 108 patients were enrolled and constituted an independent test cohort (n = 108). Patients' clinical characteristics and CT semantic features were collected. The radiomics features were derived from contrast-enhanced CT images. The clinical-semantic model and radiomics signature were built to predict LN metastasis. Furthermore, Swin Transformer was adopted to develop a DL signature predictive of LN metastasis. Model performance was evaluated by area under the receiver operating characteristic curve (AUC), sensitivity, specificity, calibration curve, and decision curve analysis. The comparisons of AUC were conducted by the DeLong test.

RESULTS: The proposed DL signature yielded an AUC of 0.948-0.961 across all three cohorts, significantly superior to both clinical-semantic model and radiomics signature (all p < 0.05). The calibration curves show that DL signature predicted probabilities fit well the actual observed probabilities of LN metastasis. DL signature gained a higher net benefit than both clinical-semantic model and radiomics signature. The incorporation of radiomics signature or clinical-semantic risk predictors failed to reveal an incremental value over the DL signature.

CONCLUSIONS: The proposed DL signature based on Swin Transformer achieved a promising performance in predicting LN metastasis and could confer important information in noninvasive mediastinal LN staging and individualized therapeutic options.

KEY POINTS: • Accurate prediction for lymph node metastasis is crucial to formulate individualized therapeutic options for patients with lung adenocarcinoma. • The deep learning signature yielded an AUC of 0.948-0.961 across all three cohorts in predicting lymph node metastasis, superior to both radiomics signature and clinical-semantic model. • The incorporation of radiomics signature or clinical-semantic risk predictors into deep learning signature failed to reveal an incremental value over deep learning signature.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Ma, Xia, Chen, et al. Development and validation of a deep learning signature for predicting lymph node metastasis in lung adenocarcinoma: comparison with radiomics signature and clinical-semantic model. Eur Radiol. 2022. PMID: 36169691. doi:10.1007/s00330-022-09153-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。